Ragan Paula
SEC CIK 1769914 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc | Pres, CEO, Dir | 3.34M | — | $699.6K | 24 | 2021-07-15 | 2025-02-12 |
Most active insiders at XFOR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Craig Adam R | Executive COB, Dir | $250.0K | $210.8K |
| 2 | KIRSKE DAVID | CFO | — | $109.2K |
| 3 | Volpone John | Pres | — | $109.2K |
Ragan Paula made no open-market trades at XFOR in the last 12 months.
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-14 | 2025-02-12 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | A - Grant | $0.00 | +2.25M | 3.34M | +207% | $0 | |
| 2025-01-27 | 2025-01-24 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | $0.45 | -76.5K | 1.09M | -7% | -$34.4K | |
| 2025-01-27 | 2025-01-23 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | A - Grant | $0.00 | +169.9K | 1.16M | +17% | $0 | |
| 2024-11-19 | 2024-11-15 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | $0.39 | -31.9K | 993.9K | -3% | -$12.4K | |
| 2024-10-16 | 2024-10-15 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | $0.56 | -31.9K | 1.03M | -3% | -$17.9K | |
| 2024-10-08 | 2024-10-04 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | A - Grant | $0.00 | +532.1K | 1.30M | +70% | $0 | |
| 2024-10-08 | 2024-10-07 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | $0.55 | -239.4K | 1.06M | -18% | -$131.7K | |
| 2024-03-11 | 2024-03-11 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | $0.88 | -49.7K | 765.1K | -6% | -$43.7K | |
| 2024-02-12 | 2024-02-12 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | $1.01 | -21.7K | 814.7K | -3% | -$21.9K | |
| M | 2023-11-03 | 2023-11-01+ | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | $0.7583 | -239.4K | 876.3K | -21% | -$181.6K |
| 2023-11-02 | 2023-10-31 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | A - Grant | $0.00 | +532.1K | 1.08M | +98% | $0 | |
| 2023-06-26 | 2023-06-23 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | $1.92 | -6,724 | 543.8K | -1% | -$12.9K | |
| 2023-06-16 | 2023-06-15 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | $2.23 | -6,724 | 550.5K | -1% | -$15.0K | |
| 2023-05-31 | 2023-05-31 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | $1.95 | -6,292 | 557.2K | -1% | -$12.3K | |
| 2023-03-13 | 2023-03-10 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | $0.84 | -49.7K | 563.5K | -8% | -$41.7K | |
| 2023-02-15 | 2023-02-13 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | $0.93 | -21.7K | 613.2K | -3% | -$20.2K | |
| 2022-08-19 | 2022-08-17 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | — | -13.4K | 634.9K | -2% | — | |
| 2022-06-27 | 2022-06-24 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | — | -6,724 | 648.4K | -1% | — | |
| 2022-06-17 | 2022-06-16 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | — | -6,724 | 655.1K | -1% | — | |
| 2022-06-06 | 2022-06-03 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | $1.21 | -6,292 | 661.8K | -0.9% | -$7,613 | |
| 2022-03-01 | 2022-03-01 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | A - Grant | $0.00 | +220.8K | 668.1K | +49% | $0 | |
| 2022-02-14 | 2022-02-11 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | — | -21.7K | 447.3K | -5% | — | |
| 2021-08-19 | 2021-08-17 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | $5.10 | -13.4K | 469.0K | -3% | -$68.6K | |
| 2021-07-16 | 2021-07-15 | XFOR | X4 Pharmaceuticals, Inc | Ragan Paula | Pres, CEO, Dir | S - Sale | $5.78 | -13.4K | 482.5K | -3% | -$77.7K |
Purchase Sale Sale after option exercise All abbreviations